NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients
India's first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years.
New Delhi: The National Technical Advisory Group on Immunisation's Covid working group has reviewed the data of Biological E's Corbevax to allow it as booster for those aged 18 and above fully vaccinated with Covishield or Covaxin, official sources said Thursday.No recommendation has yet been made in this matter by the NTAGI panel in its meeting on Wednesday.The Drugs Controller General of...
New Delhi: The National Technical Advisory Group on Immunisation's Covid working group has reviewed the data of Biological E's Corbevax to allow it as booster for those aged 18 and above fully vaccinated with Covishield or Covaxin, official sources said Thursday.
Read also: NTAGI to discuss allowing Biological Corbevax as booster for Covishield, Covaxin recipients
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd